Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Ludwig Oxford’s Mads Gyrd-Hansen, whose Senior Research Fellowship has been renewed by the Wellcome Trust. This > £1 million 5 year award will support the continuation of his research into ubiquitin signalling in immune responses.

The Gyrd-Hansen group will build on their previous investigations into the enzyme complex, LUBAC, which joins together ubiquitin molecules so that they form linear chains. These chains are important for the regulation of immune responses. Renewal of the Wellcome Trust Senior Research Fellowship will allow further research into the physiological function of LUBAC to gain an enhanced understanding of the role of ubiquitin chains in controlling the immune response.

Similar stories

Mechanistic insights into the ZBP1 inflammatory response

A collaborative study, led by former Ludwig Oxford group leader Professor Mads Gyrd-Hansen, sheds light on the ZBP1-induced signalling pathway, a pathway which contributes to the viral immune response, including to SARS-CoV-2